药物输送
材料科学
胶质瘤
靶向给药
阿霉素
纳米技术
体内
纳米颗粒
生物相容性
癌症研究
医学
生物
外科
生物技术
冶金
化疗
作者
Taotao Huo,Yafeng Yang,Min Qian,Huiling Jiang,Yilin Du,Xiaoyi Zhang,Yibo Xie,Rongqin Huang
出处
期刊:Biomaterials
[Elsevier BV]
日期:2020-08-20
卷期号:260: 120305-120305
被引量:105
标识
DOI:10.1016/j.biomaterials.2020.120305
摘要
Covalent organic framework (COF) nanoparticles for interference-free targeted drug delivery to glioma remains in its infancy. Herein, hollow COF nanospheres with high crystallinity and uniformed sizes were facilely prepared via heterogeneous nucleation-growth. The prepared COF had large surface area/pore volume and exhibited appropriate degradation behavior under acid environment, where therefore doxorubicin was effectively encapsulated and exhibited a pH-sensitive release. Most charmingly, T10 peptide that has high affinity with transferrin (Tf), was conjugated to endow the hollow COF interesting properties to specifically absorb Tf in vivo as Tf corona. For the first time, multifunctional hollow COF nanospheres (the better one named DCPT-2) were successfully synthesized to achieve interference-free cascade-targeting glioma drug delivery across the blood-brain barrier. Treatment with DCPT-2 brought an improved therapeutic outcome with significantly prolonged median survival time and low side effects. This work promised not only a potential protein corona-mediated COF-based drug delivery platform with good biocompatibility for effective and precise brain tumor therapy, but also an endogenous protein corona-mediated targeting strategy for general cancer therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI